|
|
|
|
|
|
|
Kura Oncology (KURA)
|
|
16.85 -0.05 (-0.3%)
|
05-21 16:00
|
|
Open:
|
16.9
|
Pre. Close:
|
16.9
|
|
High:
|
17.35
|
Low:
|
16.8
|
|
Volume:
|
238,658
|
Market Cap:
|
549M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
17.369 - 17.511
|
17.511 - 17.606
|
|
Low:
|
16.509 - 16.664
|
16.664 - 16.768
|
|
Close:
|
16.648 - 16.887
|
16.887 - 17.047
|
|
|
|
Technical analysis (as of: 2018-05-21 4:30:59 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 21.08 One year: 24.62
|
|
Support:
|
Support1: 15.92 Support2: 14.60
|
|
Resistance:
|
Resistance1:
18.05 Resistance2: 21.08
|
|
Pivot:
|
16.19 
|
|
Moving Averages:
|
MA(5): 16.83 MA(20): 15.96
MA(100): 18.31 MA(250): 14.11
|
|
MACD:
|
MACD(12,26):
-0.10 Signal(12,26,9): -0.36
|
|
%K %D:
|
%K(14,3): 85.48 %D(3): 86.15
|
|
RSI:
|
RSI(14): 51.80
|
|
52-Week:
|
High: 24.025
Low: 5.9 Change(%): 78.3
|
|
Average Vol(K):
|
3-Month: 27413
10-Days 23440
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.KURA has closed below upper band by 24.6%. Bollinger Bands are 34.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-05-14T10:56:05-04:00
Kura Oncology's (KURA) CEO Troy Wilson on Q1 2018 Results - Earnings Call Transcript
2018-05-08T16:15:16-04:00
Kura Oncology misses by $0.11
2018-03-16T10:26:29-04:00
Key events next week - healthcare (continued #1)
2018-03-13T17:27:17-04:00
Your Daily Pharma Scoop: Portola's New Interim Data, Lantheus Announces Promising Data For LMI 1195, Kura Tumbles On Update
2018-03-12T22:57:10-04:00
Kura Oncology's (KURA) CEO Troy Wilson on Q4 2017 Results - Earnings Call Transcript
2018-03-12T18:29:37-04:00
Kura Oncology -11.8% after earnings, regulatory update
2018-03-12T17:38:28-04:00
After Hours Gainers / Losers (3/12/2018)
2018-03-12T16:13:28-04:00
Kura Oncology misses by $0.01
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
